• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

ICYMI: Allergan Unveils AA Signature Program for Personalized Treatment

Key Takeaways

  • The AA Signature program offers a multimodal approach using Allergan's extensive product portfolio, addressing holistic patient needs in aesthetic treatments.
  • Research shows high demand for facial enhancements, with 9 in 10 seeking lift and structure, and 94% desiring improved skin quality.
SHOW MORE

This innovative approach to multimodal aesthetics care was announced at IMCAS World Congress 2025.

Allergan Aesthetics company sign | Image Credit: © JHVEPhoto - stock.adobe.com

Image Credit: © JHVEPhoto - stock.adobe.com

Allergan Aesthetics, an AbbVie company, has launched its new AA Signature program.1 The company made the announcement at this year’s IMCAS World Congress in Paris, France. The multimodal program will provide a unique and innovative approach to treatment using Allergan’s extensive product portfolio, which includes facial injectables like Botox Cosmetic and body contouring procedures such as CoolSculpting.

As more and more patients seek a holistic approach to aesthetic treatment, the AA Signature program will offer advanced training and education tools for providers on how to combine Allergan’s products. This will aim to meet multiple patient needs that are frequently brought up in clinical settings, thus enhancing retention and conversion rates. These common needs include skin quality, lift, and definition in all regions of the face.

The development of this program aligns with Allergan’s research, which demonstrates the benefits of holistic, multimodal treatment. More specifically, 9 in 10 people are looking for added lift, firmness, and structure in multiple areas of the face.2 Regarding the chin, jawline, and lower face, 1 in 3 patients seek enhanced angles and definition.3 Overall skin quality with more hydration is also a desired effect with 94% of patients wanting to improve the texture, tone, and smoothness.4

In a press release, SVP Head of International Commercial, Mark Wilson, said, "The AA Signature program addresses the rising demand for a holistic treatment approach and leverages our advanced product portfolio, providing HCPs with access to expert opinions, business support, and comprehensive educational programs - including consumer-focused and AMI-led provider training - that align with individual patient aesthetic goals."1

According to Allergan, focusing on more than one treatment area in each session will maximize patient loyalty and satisfaction. The company will continue to expand its portfolio and further utilize this new program to deliver natural-looking results for patients. Providers can connect with their local Allergan Aesthetics representative to discover whether or not the AA Signature Program is available in their country.

References

1. Allergan Aesthetics launches new AA Signature Program at IMCAS 2025 to redefine patient-centric, multimodal treatment plans. News release. Allergan Aesthetics. January 29, 2025. Accessed January 30, 2025.https://www.prnewswire.com/news-releases/allergan-aesthetics-launches-new-aa-signature-program-at-imcas-2025-to-redefine-patient-centric-multimodal-treatment-plans-302362490.html

2. Allergan Aesthetics. Data on File. Consumer Filler. March 2021.

3. Allergan Aesthetics. Data on File. Consumer Beauty Insights Survey 2021. August 2021.

4. Humphrey S, Manson Brown S, Cross SJ, Mehta R. Defining Skin Quality: Clinical Relevance, Terminology, and Assessment. Dermatol Surg. 2021;47(7):974-981. doi:10.1097/DSS.0000000000003079

Related Videos
© 2025 MJH Life Sciences

All rights reserved.